KUROSURF (Curosurf).

     Surfaktant containing fosfolipidnuyu fraction (poraktant alpha) and low hydrophobic proteins (about 1%), available from the lungs of pigs.

     Assign with respiratory distress syndrome associated with a deficit surfaktanta babies (underweight) children (weighing less than 700 grams). The use of the drug is designed to restore adequate ventilation (oxygenation).

      Enter intratrahealno as instillyatsii of 2.5 ml suspension for 1 kg of body weight. Then, a breathing bag to manually ventilation light for 1-2 minutes.

     For the selective distribution of the drug can be administered in every light to 1.25 ml / kg surfaktanta two occasions with an interval of 1 minute, turning with a child in the party and after each of conducting manual ventilation.

     Repeated instillyatsii (if required) shall at intervals of not less than 12 hours (before instillyatsy 4).

     Drug use is permitted only in clinical terms (taking into account the need for artificial ventilation and light MONITORINGS).

     Product : 8% suspension in vials of 1,5 and 3 ml (1 ml of 0.08 g (80 mg) phospholipids).

     Storage : with a temperature of 2 to 8 ° C.

Materials allowed to copy only with the active hyperlink to the handbook of medicines